B2B buyer questions
Peptide Microneedle Patch OEM FAQ
Direct answers for cosmetic brand, sourcing and product-development teams.
What is the MOQ for peptide microneedle patch OEM?
MOQ depends on formula complexity, mold requirements, packaging format and whether the order is a sample, pilot or commercial run. Share your specification and target quantity for a project-specific quotation.
Can I customize the peptide blend, needle height and patch shape?
Yes, these are common customization dimensions. Each choice is reviewed for formula compatibility, user experience, manufacturability, testing and the intended cosmetic market.
How long do samples and mass production take?
Timing begins after the brief and required materials are confirmed. Standard-platform samples are generally faster than exclusive formula, mold or packaging programs. A milestone schedule is provided with the quotation.
Do you provide full private-label packaging?
Yes. Pouch, carton, instructions, logo and pack configuration can be coordinated. Barrier performance and seal integrity are especially important for moisture-sensitive dissolvable arrays.
How is peptide activity considered during production?
The development plan considers peptide selection, pH, excipient compatibility, temperature, drying, moisture exposure, packaging and stability testing. The final control strategy is formula specific.
Are the products compliant for EU and US markets?
Compliance cannot be assigned to a generic platform. It depends on the final formula, claims, labeling, responsible-party obligations and target market. Documentation support can be scoped during development.
Which cosmetic peptides can be loaded?
Candidate options include hexapeptides, copper peptides, oligopeptides, tetrapeptides, pentapeptides and multi-peptide blends. Feasibility depends on compatibility, concentration, processing and the evidence plan.
Are these medical microneedle products?
No. This website is for cosmetic-grade dissolvable microneedle patch OEM/ODM projects. It does not offer drug-delivery, diagnostic or medical-device products.
HYTANBIO · Changzhou base
Product-portfolio questions
These answers clarify the catalogue’s material platforms, geometry language, formulation variants and packaging routes. Use them alongside the relevant product page when preparing your OEM/ODM brief.
Buyer questions
Can inner pouches and cartons both be customized?
Yes. The portfolio provides coordinated pouch, tray and carton options, with materials, finishes and dimensions defined for each project.
Can I supply finished artwork?
Yes. The two routes are design-service development or printing and packing from complete customer-supplied artwork.
What dimensions should be included in a brief?
Include patch dimensions, array geometry, backing, tray, pouch and carton requirements, together with the number of patches per pack.
What does nominal needle height mean?
It describes array geometry. It is not a measured penetration-depth claim or a universal recommended setting.
Which platform is dissolving?
HA and other water-soluble matrices form the dissolving platform. Solid PLA configurations remain non-dissolving.
Why are similar product names shown with different formulas?
The portfolio includes separate configuration profiles. Ingredient references and pack quantities should remain attached to the correct version.
Are wellness concepts proven finished products?
The portfolio alone does not establish dose, delivery, efficacy or approval. The concept page identifies the research specifications and boundaries.
HYTANBIO Microneedle Product Portfolio
22-page English catalogue · configuration, formulation and packaging references.
Portfolio specifications updated October 15, 2026 · HYTANBIO product portfolio, pages 2, 5, 6, 21. Final configuration and evidence requirements are agreed per project.
Direct answer for buyers
What should buyers know before requesting peptide microneedle patch samples?
Start by deciding whether the project is a cosmetic private-label product, a custom cosmetic formula, a new mold, or a non-commercial research prototype. Then provide the target market, application area, peptide or active direction, patch size, expected quantity, packaging and timing. This lets the manufacturer distinguish a ready-platform sample from work that needs compatibility, engineering or analytical development. Sample appearance alone is not enough for a sourcing decision; buyers should agree on acceptance criteria, documents, storage and the next scale-up stage. Claims also matter: cosmetic appearance language follows a different path from therapeutic, systemic-delivery or disease claims. The FAQ below answers commercial and technical questions without treating research evidence as finished-product approval. A useful next step is a written, non-confidential brief that records the target, assumptions, open questions, proposed evidence and decision criteria before any commercial commitment.
Key parameters
- Intended use and target market.
- Peptide, formula or benefit direction.
- Patch, array and packaging requirements.
- Sample quantity, forecast, budget and launch timing.
- Acceptance criteria, documents and claim boundary.
Questions buyers ask
Can I request a stock sample before customization?
Often yes, when a representative platform is available; it demonstrates format and handling, not final formula performance.
Can samples use my artwork?
Artwork samples may be possible, but printed packaging minimums and timing should be separated from technical samples.
What information is confidential?
Share a non-confidential brief first; detailed formula, IP and exclusivity information can follow an appropriate agreement.
Can you quote from only a peptide name?
Not reliably. Intended use, loading, patch format, customization, quantity, packaging, testing and market are also needed.
GLP-1 and therapeutic peptide inquiries
Regulatory questions from microneedle patch buyers
Can you make a Retatrutide microneedle patch?
Not as a cosmetic OEM, private-label or consumer product. Retatrutide remains investigational and is not an approved cosmetic ingredient.
Can you private label a Semaglutide or Tirzepatide microneedle patch?
No. Approved prescription injection products do not authorize a different microneedle dosage form, and these ingredients are outside the ordinary cosmetic pathway.
Do you accept pharmaceutical microneedle research inquiries?
Only bona fide institutional or pharmaceutical research discussions can be considered, subject to jurisdiction, legal authority, quality systems and regulatory review. This website does not offer unapproved consumer drug products.
Which cosmetic peptide alternatives can be developed?
Potential starting points include Acetyl Hexapeptide-8, Acetyl Octapeptide-3, Copper Tripeptide-1, selected palmitoyl peptides, Nonapeptide-1, Carnosine and multi-peptide blends, subject to project-specific validation.